Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Veracyte, Inc.. A complete text table follows the diagram.
Diagnostic testing, products, and biopharmaceutical services drive a precision-diagnostics platform.
Swipe to explore
Labels and displayed flow values are reported filing values or exact disclosed subtotals.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Veracyte revenue | 1 | $139M | $139.071M reported quarterly revenue |
| Diagnostic testing revenue | 2 | $135M | Reported testing revenue |
| Product revenue | 2 | $3.7M | Reported product revenue |
| Biopharmaceutical and other revenue | 2 | $0.3 | Reported biopharmaceutical and other revenue |
| From | To | Value |
|---|---|---|
| Veracyte revenue | Diagnostic testing revenue | $135M |
| Veracyte revenue | Product revenue | $3.7M |
| Veracyte revenue | Biopharmaceutical and other revenue | $0.3 |